All Stories

  1. Genome-wide association for sarcoidosis identifies novel risk loci and genetic heritability in African and European ancestries: a meta-analysis from the Finngen, Million Veteran Program, UK Biobank, and Biobank Japan datasets
  2. Digital twins of acute hypoxemic respiratory failure and sepsis patients suggest potential benefits of bi-level high flow nasal cannula therapy
  3. Stent and Resection Anastomosis in Patients with Complex Tracheal Stenosis: The Stars Retrospective Multicenter Trial
  4. Ultrasound-based evaluation of inspiratory muscle effort in patients with type 2 respiratory failure secondary to exacerbation of chronic obstructive pulmonary disease
  5. Optimization of intranasal bleomycin dose for effective pulmonary fibrosis induction in mice with minimal animal distress
  6. Evaluating the effect of heart and respiratory rate measurement errors on the ability to predict the outcome of high flow nasal cannula therapy: a multi-centre study
  7. Predicting and Treating Pulmonary Fibrosis with Proteomic Biomarker Investigations
  8. Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial
  9. Assessing inspiratory drive and effort in critically ill patients at the bedside
  10. Early prediction of non-invasive ventilation outcome using the TabPFN machine learning model: a multi-centre validation study
  11. Refining the predictive value of nasal pressure swing in acute hypoxemic respiratory failure management. Author's reply
  12. The use of the MoCA in cognitive impairment for older patients with Chronic Obstructive Pulmonary disease: A preliminary study
  13. Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents
  14. Digital twins suggest a mechanistic basis for differing responses to increased flow rates during high-flow nasal cannula therapy
  15. Assessment of nasal pressure swing predicts respiratory support dependency in patients with hypoxic respiratory failure
  16. Role of COVID‐19 in the Progression of Scleroderma Interstitial Lung Disease and New Onset Pulmonary Hypertension: A Challenging Case Report
  17. The Link Between Sleep-Related Breathing Disorders and Idiopathic Pulmonary Fibrosis: Pathophysiological Mechanisms and Treatment Options—A Review
  18. Machine learning models compared with current clinical indices to predict the outcome of high flow nasal cannula therapy in acute hypoxemic respiratory failure
  19. Respiratory Muscle Dysfunction and Associated Risk Factors Following COVID-19-Related Hospitalisation
  20. Airway pressures generated by high flow nasal cannula in patients with acute hypoxemic respiratory failure: a computational study
  21. Genetic Risk Factors in Idiopathic and Non-Idiopathic Interstitial Lung Disease: Similarities and Differences
  22. Rehabilitation and physiotherapists in the critical care medicine
  23. Development of clinical tools to estimate the breathing effort during high-flow oxygen therapy: A multicenter cohort study
  24. Quantitative CT-analysis of over aerated lung tissue and correlation with fibrosis extent in patients with idiopathic pulmonary fibrosis
  25. Bronchiectasis as long-term complication of acute fire smoke inhalation?
  26. Monitoring and modulation of respiratory drive in patients with acute hypoxemic respiratory failure in spontaneous breathing
  27. Influence of frailty on cardiovascular events and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD): Study protocol for a multicentre European observational study
  28. Expression of HOXB7 in the Lung of Patients with Idiopathic Pulmonary Fibrosis: A Proof-of-Concept Study
  29. Stress–strain curve and elastic behavior of the fibrotic lung with usual interstitial pneumonia pattern during protective mechanical ventilation
  30. Digital Twins of Acute Hypoxemic Respiratory Failure Patients Suggest a Mechanistic Basis for Success and Failure of Noninvasive Ventilation
  31. Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
  32. Integrated endoscopic treatment of primitive unresectable tracheal tumor: the INTACT retrospective cohort study
  33. When sarcoidosis hits down: a case of prostatic sarcoidosis
  34. Influence of frailty on cardiovascular events and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD): Study Protocol for a multicentre European observational study
  35. Editorial: Pulmonary fibrosis and lung carcinogenesis: do myofibroblasts and cancer-associated fibroblasts share a common identity?
  36. Impact of Frailty on Symptom Burden in Chronic Obstructive Pulmonary Disease
  37. Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis
  38. Efficacy of Respiratory Muscle Training in the Immediate Postoperative Period of Cardiac Surgery: A Systematic Review and Meta-Analysis
  39. Home noninvasive ventilation in severe COPD: in whom does it work and how?
  40. Effect of high flow nasal oxygen on inspiratory effort of patients with acute hypoxic respiratory failure and do not intubate orders
  41. COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome
  42. Disease burden of people with uncontrolled severe asthma with and without biomarkers of inflammation
  43. Inspiratory Effort and Respiratory Mechanics in Patients with Acute Exacerbation of Idiopathic Pulmonary fibrosis: A Preliminary Matched Control Study
  44. Stress-strain curve and elastic behavior of the fibrotic lung with usual interstitial pneumonia pattern during protective mechanical ventilation
  45. Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study
  46. Physiological effects of lung-protective ventilation in patients with lung fibrosis and usual interstitial pneumonia pattern versus primary ARDS: a matched-control study
  47. The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients
  48. Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials
  49. Frailty and its influence on mortality and morbidity in COPD: A Systematic Review and Meta-Analysis
  50. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
  51. Frailty Prevalence and Association with Clinical Outcomes in Interstitial Lung Disease, Asthma, and Pleural Disease
  52. Molecular Biology and Therapeutic Targets of Primitive Tracheal Tumors: Focus on Tumors Derived by Salivary Glands and Squamous Cell Carcinoma
  53. Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes
  54. Critical COVID-19 patients through first, second, and third wave: retrospective observational study comparing outcomes in intensive care unit
  55. Prevalence of asthma and COPD in a cohort of patients at the follow up after COVID-19 pneumonia
  56. One‐year clinical experience on the use of Nintedanib in systemic sclerosis
  57. Case report: Endoscopic closure with double stenting and autologous fascia lata graft of large tracheo-esophageal fistula
  58. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
  59. Accuracy of Nasal Pressure Swing to Predict Failure of High-Flow Nasal Oxygen in Patients with Acute Hypoxemic Respiratory Failure
  60. Role of Selective Digestive Decontamination in the Prevention of Ventilator-Associated Pneumonia in COVID-19 Patients: A Pre-Post Observational Study
  61. COPD: Providing the right treatment for the right patient at the right time
  62. Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
  63. Endoscopic Bronchopleural Fistula Repair Using Autologous Fat Graft
  64. Biological effects of COVID-19 on lung cancer: Can we drive our decisions
  65. Delirium incidence and risk factors in patients undergoing non-invasive ventilation for acute respiratory failure: a multicenter observational trial
  66. Comparison between first and second wave of COVID-19 outbreak in older people: the COPE multicentre European observational cohort study
  67. The burden of disease in people with mild asthma
  68. Treatable traits in the NOVELTY study
  69. The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance
  70. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
  71. High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
  72. Persistent asthma hospitalisations and deaths require a national asthma prevention plan
  73. Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study
  74. Risk Factors for Pulmonary Air Leak and Clinical Prognosis in Patients With COVID-19 Related Acute Respiratory Failure: A Retrospective Matched Control Study
  75. Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure
  76. Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update
  77. Rehabilitation of Difficult-to-Wean, Tracheostomized Patients Admitted to Specialized Unit: Retrospective Analyses over 10-Years
  78. Stenting versus balloon dilatation in patients with tracheal benign stenosis: The STROBE trial
  79. Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults
  80. Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study
  81. Correction: Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia
  82. Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome
  83. First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
  84. Extensive Tracheal Injuries: A Reasoned Multistep Approach to Guarantee Mechanical Ventilatory Support Developed During the COVID‐19 Pandemic
  85. Development of post-COVID-19 cardiovascular events: an analysis of clinical features and risk factors from a single hospital retrospective study
  86. In memoriam Claudio F. Donner
  87. Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndrome
  88. Urgent need of novel biomarkers of acute dyspnea
  89. Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
  90. Acute severe asthma: management and treatment
  91. Combined approach to define the clinical impact and decision making in asthmatics
  92. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
  93. Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia
  94. ERS/EAACI statement on adherence to international adult asthma guidelines
  95. Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure due to COVID-19: A Matched Control Study
  96. Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study
  97. Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
  98. Changes in Clinical Characteristics and Outcomes of Patients Admitted to Inpatient Cardiac Rehabilitation
  99. Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
  100. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
  101. Rehabilitative practice in Europe: Roles and competencies of physiotherapists. Are we learning something new from COVID-19 pandemic?
  102. Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution
  103. Pulmonary Stretch and Lung Mechanotransduction: Implications for Progression in the Fibrotic Lung
  104. Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association
  105. Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study
  106. Never Give Up: Lesson learned from a severe COVID-19 patient
  107. Defining Modern Pulmonary Rehabilitation. An Official American Thoracic Society Workshop Report
  108. Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D’Amato et al.
  109. Spontaneous Breathing and Evolving Phenotypes of Lung Damage in Patients with COVID-19: Review of Current Evidence and Forecast of a New Scenario
  110. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection
  111. Looking Ahead in Pulmonary Rehabilitation
  112. Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19
  113. Reply to Spinelli et al. and to Jha: Continued Vigorous Inspiratory Effort as a Predictor of Noninvasive Ventilation Failure
  114. High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial
  115. Increased care at discharge from COVID-19: The association between pre-admission frailty and increased care needs after hospital discharge; a multicentre European observational cohort study
  116. The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
  117. Unusual effectiveness of systemic steroids in Whipple disease
  118. Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—Challenges, strengths, and opportunities in a global health emergency
  119. Echoendoscopic appearance of mediastinal metastasis from papillary renal carcinoma
  120. Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE)
  121. Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople)
  122. Reply to Tuffet et al. and to Michard and Shelley
  123. Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies
  124. Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study
  125. Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia
  126. Tocilizumab in patients with severe COVID-19: a retrospective cohort study
  127. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study
  128. Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease
  129. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
  130. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a st...
  131. Italian suggestions for pulmonary rehabilitation in COVID-19 patients recovering from acute respiratory failure: results of a Delphi process
  132. COVID-19 and pulmonary rehabilitation: preparing for phase three
  133. Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis
  134. An Italian sacrifice to the COVID-19 epidemic
  135. High-Flow Oxygen Therapy During Exercise Training in Patients With Chronic Obstructive Pulmonary Disease and Chronic Hypoxemia: A Multicenter Randomized Controlled Trial
  136. Handling and Processing of Blood Specimens from Patients with COVID‐19 for Safe Studies on Cell Phenotype and Cytokine Storm
  137. Obstructive sleep apnea and blood pressure in young hypertensives: does it matter?
  138. Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball”
  139. Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia
  140. Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper
  141. Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients
  142. Vessel Diseases
  143. A case of dyspnea: respiratory failure due to pulmonary arteriovenous malformation
  144. Prognostication by concomitant organ failure in mechanically ventilated patients in ICU: Important issue to face with
  145. Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment
  146. Respiratory Mechanics and Diaphragmatic Dysfunction in COPD Patients Who Failed Non-Invasive Mechanical Ventilation
  147. Prevalence and development of chronic critical illness in acute patients admitted to a respiratory intensive care setting
  148. Gender differences in chronic obstructive pulmonary disease: Can be the DRG-based diagnosis the best way for a right analysis?
  149. Atypical diagnosis for typical lung carcinoid
  150. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD
  151. Serial ultrasound assessment of diaphragmatic function and clinical outcome in patients with amyotrophic lateral sclerosis
  152. Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
  153. Janus-faced amiodarone-induced pneumopathy
  154. Clinical differences in sarcoidosis patients with and without lymphoma
  155. Do Not Forget to Assess the Muscle Integrity in Patients With COPD
  156. Introduction of the harmonised respiratory physiotherapy curriculum
  157. A guide for respiratory physiotherapy postgraduate education: presentation of the harmonised curriculum
  158. Manual Massage Therapy for Patients with COPD: A Scoping Review
  159. Exercise and Sports Pulmonology
  160. Cardiac disease
  161. Pulmonary Rehabilitation
  162. Assessment of Symptoms in Patients with COPD: Strengths and Limitations of Clinical Scores
  163. LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review
  164. Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure
  165. Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure
  166. An uncommon cause of hemoptysis: aortobronchial fistula
  167. Tai Chi Recreational Exercise Is Not Rehabilitation
  168. Evaluation of health-related quality of life in pulmonary diseases
  169. The encaged lung: rapidly progressive idiopathic pleurisy
  170. Vanishing lung emphysema during chemotherapy for malignant pleural mesothelioma
  171. Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD
  172. Ultrasound-assessed diaphragmatic impairment is a predictor of outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease undergoing noninvasive ventilation
  173. Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
  174. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
  175. Update in rehabilitation of respiratory patients
  176. Looking for a chronic care model in COPD patients
  177. Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
  178. Incidence, Etiology, and Clinicopathologic Features of Endobronchial Benign Lesions
  179. Conventional Programs: Settings, Cost, Staffing, and Maintenance
  180. Conclusions: Perspectives in Pulmonary Rehabilitation
  181. Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study
  182. Chronic Respiratory Abnormalities in the Multi-Morbid Frail Elderly
  183. Update on physiotherapy applicable to patients in intensive care. Practical aspects and perspectives
  184. Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects
  185. The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients
  186. Integrating the care of the complex COPD patient
  187. GOLD 2017 recommendations for COPD patients: toward a more personalized approach
  188. COPD exacerbation and diaphragmatic dysfunction: Conditions with mutual influence influencing outcomes? - Reply
  189. An uncommon cause of pneumonia: The golden diagnosis
  190. Prevalence and outcomes of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of COPD: A pilot study
  191. What is the origin of dyspnoea in smokers without airway disease?
  192. Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement
  193. Management and Therapy for Pulmonary Hypertension: 2016 Update
  194. Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis
  195. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease
  196. Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers
  197. Activity and analysis of costs in a dedicated weaning centre
  198. Learning impact of education during Pulmonary Rehabilitation program. An observational short-term cohort study
  199. Organization of a Weaning Unit
  200. La ventilazione non invasiva in Medicina Interna
  201. Advanced COPD patients under Home Mechanical Ventilation and/or Long Term Oxygen Therapy: Italian Healthcare Costs
  202. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation
  203. Response to pulmonary rehabilitation: toward personalised programmes?
  204. Chronic critical illness: the price of survival
  205. 8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – Part 3
  206. 8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 2
  207. 8th international conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 1
  208. Comorbidities in elderly smokers with COPD or CHF
  209. Impaired function in the complex patient with COPD: a matter to be considered
  210. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
  211. Clinical highlights: messages from Munich
  212. Development of a syllabus for postgraduate respiratory physiotherapy education: the Respiratory Physiotherapy HERMES project
  213. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
  214. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
  215. A Prospective Multicentric Study of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease and Different Clinical Phenotypes
  216. Symptomatic, frail, elderly patients: the urgent need for comprehensive assessment and management: Figure 1–
  217. A conceptual framework for reporting experience of physical activity in COPD
  218. Pulmonary rehabilitation in Italy: professional barriers to overcome
  219. An official European Respiratory Society statement on physical activity in COPD
  220. A core syllabus for post-graduate training in respiratory physiotherapy
  221. In COPD patients on prolonged mechanical ventilation heart rate variability during the T-piece trial is better after pressure support plus PEEP: A pilot physiological study
  222. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial
  223. Impaired arm activity in COPD: a questionable goal for rehabilitation
  224. Clinical highlights from the 2013 ERS Congress in Barcelona
  225. Rehabilitation and supportive therapy in elderly patients with Chronic Obstructive Pulmonary Disease
  226. Comorbidities in Chronic Obstructive Pulmonary Disease from Assessment to Treatment
  227. Multimorbidity in Elderly Patients with Chronic Obstructive Pulmonary Disease: Stop Smoking! Go Exercise?
  228. Differences in content and organisational aspects of pulmonary rehabilitation programmes
  229. Fat-Free Mass Depletion Is Associated With Poor Exercise Capacity Irrespective of Dynamic Hyperinflation in COPD Patients
  230. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
  231. Chronic Obstructive Pulmonary Disease (COPD) and Metabolic Disorders in Elderly Smokers
  232. Towards health benefits in chronic respiratory diseases: pulmonary rehabilitation
  233. Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease
  234. Noninvasive mechanical ventilation with high pressure strategy remains a “double edged sword”?
  235. Systemic Inflammatory Pattern of Patients With Community-Acquired Pneumonia With and Without COPD
  236. Diagnosis of Chronic Obstructive Pulmonary Disease, simpler is better Complexity and simplicity
  237. Chronic Obstructive Pulmonary Disease Is Just One Component of the Complex Multimorbidities in Patients with COPD
  238. Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease
  239. Predicting Walking-Induced Oxygen Desaturations in COPD Patients: A Statistical Model
  240. Feasibility and Effectiveness of an Educational Program in Italian COPD Patients Undergoing Rehabilitation
  241. Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals
  242. Effect of Rehabilitative Exercise Training on Peripheral Muscle Remodelling in Patients with COPD: Targeting Beyond the Lungs
  243. Pulmonary Rehabilitation Improves Cardiovascular Response to Exercise in COPD
  244. Respiratory Muscle Training in Patients Recovering Recent Open Cardiothoracic Surgery: A Randomized-Controlled Trial
  245. Selected clinical highlights from the 2012 ERS congress in Vienna: Table 1–
  246. Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial
  247. Pulmonary rehabilitation following radical chemo-radiation in locally advanced non surgical NSCLC: Preliminary evidences
  248. Clinical highlights from the 2011 ERS Congress in Amsterdam
  249. Anthropometry in Special and Selective Conditions and Circumstances: Anthropometry as Measure of Risk in COPD Patients
  250. Rehabilitation, weaning and physical therapy strategies in chronic critically ill patients
  251. Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients
  252. Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation
  253. Co-morbidities in chronic respiratory patients: limitations or opportunities for caring?
  254. COPD and the metabolic syndrome: an intriguing association
  255. Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients
  256. Energy Expenditure at Rest and during Walking in Patients with Chronic Respiratory Failure: A Prospective Two-Phase Case-Control Study
  257. Rehabilitation in COPD patients: evergreen in pneumology and beyond
  258. Safety and Efficacy of Short-Term Intrapulmonary Percussive Ventilation in Patients With Bronchiectasis
  259. Selected clinical highlights from the 2010 ERS Congress in Barcelona
  260. Complessità del paziente con insufficienza respiratoria cronica associata a BPCO
  261. Functional Recovery Following Physical Training in Tracheotomized and Chronically Ventilated Patients
  262. Non-invasive ventilation in elderly patients with acute hypercapnic respiratory failure: a randomised controlled trial
  263. Non-invasive Ventilation and Weaning: Principles and Practice
  264. Early Rehabilitation
  265. Efficacy of standard rehabilitation in COPD outpatients with comorbidities
  266. Measures of dyspnea in pulmonary rehabilitation
  267. Lung function evaluation before surgery in lung cancer patients: how are recent advances put into practice? A survey among members of the European Society of Thoracic Surgeons (ESTS) and of the Thoracic Oncology Section of the European Respiratory Soci...
  268. Erratum to: Subjective Sleep Quality During Average Volume Assured Pressure Support (AVAPS) Ventilation in Patients with Hypercapnic COPD: A Physiological Pilot Study
  269. Effects of early inpatient rehabilitation after acute exacerbation of COPD
  270. Patients’ characterization, hospital course and clinical outcomes in five Italian respiratory intensive care units
  271. "ERS/ESTS CLINICAL GUIDELINES ON FITNESS FOR RADICAL THERAPY IN LUNG CANCER PATIENTS (SURGERY AND CHEMO-RADIOTHERAPY)". A. BRUNELLI, A. CHARLOUX, C.T. BOLLIGER, G. ROCCO, J-P. SCULIER, G. VARELA, M. LICKER, M.K. FERGUSON, C. FAIVRE-FINN, R.M. HUBER, E....
  272. Last 3 months of life in home-ventilated patients: the family perception
  273. Subjective Sleep Quality During Average Volume Assured Pressure Support (AVAPS) Ventilation in Patients with Hypercapnic COPD: A Physiological Pilot Study
  274. Effects of Unsupported Upper Extremity Exercise Training in Patients With COPD
  275. Long-term Weight Loss and Maintenance in Morbidly Obese Individuals with Obstructive Sleep Apnea
  276. The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer
  277. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
  278. Short-term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review
  279. Use of functional independence measure in rehabilitation of inpatients with respiratory failure
  280. Exercise Capacity as a Pulmonary Rehabilitation Outcome
  281. Home-centred physical fitness programme in morbidly obese individuals: a randomized controlled trial
  282. Role of hyperinflation vs. deflation on dyspnoea in severely to extremely obese subjects
  283. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation
  284. Predictors of 6-Month Mortality in Elderly Patients with Mild Chronic Obstructive Pulmonary Disease Discharged from a Medical Ward After Acute Nonacidotic Exacerbation
  285. Home Non-Invasive Mechanical Ventilation and Long-Term Oxygen Therapy in Stable Hypercapnic Chronic Obstructive Pulmonary Disease Patients: Comparison of Costs
  286. Indications and Physiological Basis of Rehabilitation in the ICU
  287. Nutrition in ICU
  288. Nonpharmacological treatment and relief of symptoms in COPD
  289. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study
  290. Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer
  291. Effects of a Walking Aid in COPD Patients Receiving Oxygen Therapy
  292. Respiratory muscles training in COPD patients
  293. Intrapulmonary percussive ventilation in tracheostomized patients: a randomized controlled trial
  294. Maximal inspiratory and expiratory pressure measurement in tracheotomised patients
  295. Repeated Pulmonary Rehabilitation in Severe and Disabled COPD Patients
  296. Inspiratory Muscle Training: A Way to Breathe More Easily
  297. EFFECTIVENESS OF A REHABILITATION PROGRAM IN MORBIDLY OBESE SUBJECTS WITH SLEEP DISTURBANCIES
  298. Supported Arm Training in Patients Recently Weaned From Mechanical Ventilation
  299. Early physiotherapy in the respiratory intensive care unit
  300. Length and Clinical Effectiveness of Pulmonary Rehabilitation in Outpatients With Chronic Airway Obstruction
  301. Inpatient pulmonary rehabilitation: does it make sense?
  302. Assessment of Physiologic Variables and Subjective Comfort Under Different Levels of Pressure Support Ventilation
  303. Inspiratory muscle workload due to dynamic intrinsic PEEP in stable COPD patients: effects of two different settings of non-invasive pressure-support ventilation
  304. Long-term mechanical ventilation and nutrition
  305. Occupational Therapy and Pulmonary Rehabilitation of Disabled COPD Patients
  306. Effects of Respiratory Therapist-Directed Protocol on Prescription and Outcomes of Pulmonary Rehabilitation in COPD Inpatients
  307. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients
  308. Exhaled nitric oxide and exercise tolerance in severe COPD patients
  309. In-Hospital Short-term Training Program for Patients With Chronic Airway Obstruction
  310. Physiological Response to Pressure Support Ventilation Delivered before and after Extubation in Patients Not Capable of Totally Spontaneous Autonomous Breathing
  311. Erratum
  312. Comparison of Two Methods for Weaning Patients with Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation for More Than 15 Days
  313. Effect of pulmonary rehabilitation on exhaled nitric oxide in patients with chronic obstructive pulmonary disease
  314. Exhaled nitric oxide in patients with PiZZ Phenotype-related α 1-anti-trypsin deficiency
  315. The Appropriate Setting of Noninvasive Pressure Support Ventilation in Stable COPD Patients
  316. Production of Endogenous Nitric Oxide in Chronic Obstructive Pulmonary Disease and Patients with Cor Pulmonale
  317. Physiologic effects of early administered mask proportional assist ventilation in patients with chronic obstructive pulmonary disease and acute respiratory failure
  318. Preliminary results on nursing workload in a dedicated weaning center
  319. Endogenous nitric oxide in patients with chronic heart failure (CHF): relation to functional impairment and nitrate-containing therapies
  320. Exhaled Nitric Oxide and Exercise in Stable COPD Patients
  321. Physiological effects of posture on mask ventilation in awake stable chronic hypercapnic COPD patients
  322. DETECTION OF NITRIC OXIDE IN EXHALED AIR OF DIFFERENT ANIMAL SPECIES USING A CLINICAL CHEMILUMINESCENCE ANALYSER
  323. Differences in spontaneous breathing pattern and mechanics in patients with severe COPD recovering from acute excerbation
  324. Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation
  325. Acute effects of deep diaphragmatic breathing in COPD patients with chronic respiratory insufficiency
  326. Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis
  327. Evaluation in pulmonary rehabilitation
  328. Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation
  329. Association therapy as a prognostic factor in deep fungal infection complicating oncohaematological diseases
  330. Transcutaneous Partial Oxygen Tension and Lung Mechanics During Methacholine Inhaled Challenge
  331. Ceftizoxime in Lower Respiratory Tract Infection